Taeho Kim, PhD, has been selected for funding from the Siteman Investment Program. His proposal, “MRI Augmented X-ray imaging-guided Adaptive RadioTherapy for pancreatic cancer (MAX-guided ART)” will receive funds in the amount of $199,921 direct costs over 2 years, beginning on July 1, 2021.”
PI: Taeho Kim, PhD
Co-investigators:
Henke, Lauren Elizabeth
Hugo, Geoffrey
Schmidt, Matthew
Huang, Yi
Villa, Umberto
Collaborator: Park, Justin Chunjoo